Fair Value Measurement
The Company reports assets and liabilities recorded at fair value on the Company’s consolidated balance sheets based upon the level of judgment associated with inputs used to measure their fair value.
The fair value measurement level within the fair value hierarchy for a particular asset or liability is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques maximize the use of observable inputs and minimize the use of unobservable inputs.
Financial instruments not measured at fair value on the Company’s consolidated statement of financial position, but which require disclosure of their fair values include cash and cash equivalents, deposits, liquidity contract, accounts payable, and conditional advances. The fair values of these financial instruments are deemed to approximate their carrying amount.
There has been no transfer between levels of the fair value hierarchy during the years ended December 31, 2024 and 2025.
The financial instruments recognized on the balance sheet are analyzed as follows as of December 31, 2024 :

Breakdown by financial instrument class - balance sheet valueLevel of fair value
2024
(in thousands of dollars)
Carrying valueFair value through P&LAssets at amortized costLiabilities at amortized cost Derivative financial instrumentLevel 1Level 2Level 3
Deposits4,3124,312
Liquidity contract111111111
Accounts receivable680680
Cash and cash equivalents 32,45632,45632,456
Total Assets37,55932,5674,99232,567
Other liabilities8,328008,3280000
Accounts payables22,0320022,0320000
Total Liabilities30,36030,360

The financial instruments recognized on the balance sheet are analyzed as follows as of December 31, 2025 :
Breakdown by financial instrument class - balance sheet valueLevel of fair value
Carrying valueFair value through P&LAssets at amortized costLiabilities at amortized costDerivative financial instrumentLevel 1Level 2Level 3
Deposits5,18905,18900000
Liquidity contract62062000062000
Cash and cash equivalents 194,167194,167000194,16700
Total Assets199,977194,7885,189194,788
Other liabilities15,7505015,7505500
Accounts payables40,9410040,9410000
Total Liabilities56,691556,69155

Financial instruments evolved during the year primarily as a result of the financings conducted resulting in a significant increase in cash and cash equivalents .
Derivative Instruments
The Company is exposed to increasing foreign exchange risk due to a portion of its procurement activities being conducted in the United States and invoiced in U.S. dollars, as well as the activity of its subsidiary DBV Technologies Inc., in connection with the Company’s preparation for the potential launch of the VIASKIN Peanut patch in the United States, if approved.
This exposure has been increased by the continued depreciation of the U.S. dollar observed over the past year, which increases volatility and uncertainty regarding foreign‑currency‑denominated operating costs.
In this context, since 2025, the Company has hedged the current account of its US subsidiary through the use of financial instruments (foreign exchange swaps entered into with banking counterparties), which are linked to the subsidiary’s current account as of December 31, 2025.
The Company’s policy is not to enter into derivative transactions for speculative purposes.

(In Million of dollars)As of December 31, 2025
Notional amount Fair valueDue date
AssetLiabilities<1 year1 – 5 years>5 years
Foreign exchange SWAP
Forward sale at maturity
Non-qualified derivative1,8001,800
The impact of financial instruments not qualifying for hedge accounting of future cash flows is included in “Foreign exchange gains/(losses) (excluding operating activities)” within financial result ($(5) thousand as of December 31, 2025). The Company did not hold any derivative instruments in 2024.

Historical Timeline

Fiscal YearFiled
2025Mar 26, 2026Showing above
2024Apr 11, 2025
2023Mar 7, 2024
2022Mar 2, 2023
2021Mar 9, 2022
2020Mar 17, 2021

About Fair Value Disclosures

Fair value disclosures classify all assets and liabilities measured at fair value into a three-level hierarchy: Level 1 (quoted market prices), Level 2 (observable inputs like yield curves), and Level 3 (unobservable inputs requiring management estimates). The proportion of Level 3 assets directly reflects how much of the balance sheet depends on internal models rather than market evidence.

Key signals: a growing Level 3 balance relative to total fair-value assets increases valuation uncertainty and earnings volatility risk. Watch for transfers between levels — assets moving from Level 2 to Level 3 often signal deteriorating market liquidity. Unrealized gains and losses on Level 3 positions flow through earnings or other comprehensive income, so large swings deserve scrutiny. For financial institutions, examine the sensitivity disclosures that show how Level 3 valuations change under alternative assumptions. Compare the fair value of debt against its carrying amount to gauge hidden leverage.